Correlation Between Vyne Therapeutics and Editas Medicine
Can any of the company-specific risk be diversified away by investing in both Vyne Therapeutics and Editas Medicine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vyne Therapeutics and Editas Medicine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vyne Therapeutics and Editas Medicine, you can compare the effects of market volatilities on Vyne Therapeutics and Editas Medicine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vyne Therapeutics with a short position of Editas Medicine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vyne Therapeutics and Editas Medicine.
Diversification Opportunities for Vyne Therapeutics and Editas Medicine
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Vyne and Editas is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Vyne Therapeutics and Editas Medicine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Editas Medicine and Vyne Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vyne Therapeutics are associated (or correlated) with Editas Medicine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Editas Medicine has no effect on the direction of Vyne Therapeutics i.e., Vyne Therapeutics and Editas Medicine go up and down completely randomly.
Pair Corralation between Vyne Therapeutics and Editas Medicine
Given the investment horizon of 90 days Vyne Therapeutics is expected to generate 1.84 times more return on investment than Editas Medicine. However, Vyne Therapeutics is 1.84 times more volatile than Editas Medicine. It trades about 0.11 of its potential returns per unit of risk. Editas Medicine is currently generating about -0.09 per unit of risk. If you would invest 239.00 in Vyne Therapeutics on October 20, 2024 and sell it today you would earn a total of 31.00 from holding Vyne Therapeutics or generate 12.97% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vyne Therapeutics vs. Editas Medicine
Performance |
| Timeline |
| Vyne Therapeutics |
| Editas Medicine |
Vyne Therapeutics and Editas Medicine Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vyne Therapeutics and Editas Medicine
The main advantage of trading using opposite Vyne Therapeutics and Editas Medicine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vyne Therapeutics position performs unexpectedly, Editas Medicine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Editas Medicine will offset losses from the drop in Editas Medicine's long position.| Vyne Therapeutics vs. Akari Therapeutics PLC | Vyne Therapeutics vs. Salarius Pharmaceuticals | Vyne Therapeutics vs. SAB Biotherapeutics | Vyne Therapeutics vs. GeoVax Labs |
| Editas Medicine vs. Beam Therapeutics | Editas Medicine vs. Crispr Therapeutics AG | Editas Medicine vs. Caribou Biosciences | Editas Medicine vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| CEOs Directory Screen CEOs from public companies around the world |